nodes	percent_of_prediction	percent_of_DWPC	metapath
Medroxyprogesterone Acetate—CYP3A4—bone cancer	0.424	1	CbGaD
Medroxyprogesterone Acetate—AKR1C3—Doxorubicin—bone cancer	0.288	0.897	CbGbCtD
Medroxyprogesterone Acetate—CYP2C9—Cisplatin—bone cancer	0.0237	0.0738	CbGbCtD
Medroxyprogesterone Acetate—CYP3A4—Doxorubicin—bone cancer	0.00925	0.0288	CbGbCtD
Medroxyprogesterone Acetate—Hydrocortamate—CYP3A4—bone cancer	0.000505	0.15	CrCbGaD
Medroxyprogesterone Acetate—Cortisone acetate—CYP3A4—bone cancer	0.000497	0.148	CrCbGaD
Medroxyprogesterone Acetate—Eplerenone—CYP3A4—bone cancer	0.000436	0.13	CrCbGaD
Medroxyprogesterone Acetate—Drospirenone—PTGS2—bone cancer	0.00041	0.122	CrCbGaD
Medroxyprogesterone Acetate—Fluorometholone—CYP3A4—bone cancer	0.00038	0.113	CrCbGaD
Medroxyprogesterone Acetate—Methylprednisolone—CYP3A4—bone cancer	0.000367	0.109	CrCbGaD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—CDK4—bone cancer	0.000318	0.00418	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Constitutive Androstane Receptor Pathway—CYP3A4—bone cancer	0.000315	0.00414	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Gene Expression—ZNF77—bone cancer	0.000314	0.00413	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metapathway biotransformation—GSTP1—bone cancer	0.000302	0.00397	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.0003	0.00394	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000281	0.00369	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—RB1—bone cancer	0.000276	0.00363	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—MMP2—bone cancer	0.00027	0.00355	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—CYP4V2—bone cancer	0.00027	0.00355	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—FOXM1 transcription factor network—MMP2—bone cancer	0.000265	0.00348	CbGpPWpGaD
Medroxyprogesterone Acetate—Methyltestosterone—CYP3A4—bone cancer	0.000263	0.078	CrCbGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—bone cancer	0.000263	0.00345	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—RB1—bone cancer	0.000257	0.00338	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—PLAU—bone cancer	0.000256	0.00337	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—FOXA1 transcription factor network—JUN—bone cancer	0.000256	0.00337	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000254	0.00334	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.000249	0.00327	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000245	0.00322	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000244	0.00321	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—CDK4—bone cancer	0.000242	0.00318	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—ZNF77—bone cancer	0.000239	0.00315	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000239	0.00314	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—JUN—bone cancer	0.000237	0.00311	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000236	0.0031	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000234	0.00308	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000231	0.00304	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—PLAU—bone cancer	0.000223	0.00294	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Generic Transcription Pathway—NR1I2—bone cancer	0.000221	0.00291	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of Androgen receptor activity—JUN—bone cancer	0.000221	0.0029	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—PLAU—bone cancer	0.00022	0.00289	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000217	0.00286	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—WT1—bone cancer	0.000216	0.00284	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NDUFA12—bone cancer	0.000215	0.00282	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	0.000211	0.00278	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—RB1—bone cancer	0.00021	0.00277	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—bone cancer	0.000205	0.0027	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000204	0.00269	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Plasma membrane estrogen receptor signaling—MMP9—bone cancer	0.000203	0.00267	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—MMP2—bone cancer	0.000202	0.00265	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.0002	0.00263	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000198	0.0026	CbGpPWpGaD
Medroxyprogesterone Acetate—Hydrocortisone—CYP3A4—bone cancer	0.000198	0.0587	CrCbGaD
Medroxyprogesterone Acetate—ESR1—FOXA1 transcription factor network—JUN—bone cancer	0.000197	0.00259	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—RB1—bone cancer	0.000197	0.00259	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.000195	0.00257	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of Androgen receptor activity—MDM2—bone cancer	0.000193	0.00253	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.00019	0.0025	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.00019	0.00249	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—ATF1—bone cancer	0.000189	0.00248	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000188	0.00247	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000188	0.00247	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—bone cancer	0.000185	0.00243	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—ZNF77—bone cancer	0.000184	0.00243	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—SMO—bone cancer	0.000184	0.00242	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—KIT—bone cancer	0.000182	0.00239	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—ZNF77—bone cancer	0.000182	0.00239	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CHEK2—bone cancer	0.000182	0.00239	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—NT5C3A—bone cancer	0.000178	0.00234	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Generic Transcription Pathway—NR1I2—bone cancer	0.000168	0.00221	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—MDM2—bone cancer	0.000168	0.0022	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—bone cancer	0.000168	0.0022	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Regulation of Androgen receptor activity—JUN—bone cancer	0.000167	0.0022	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000166	0.00218	CbGpPWpGaD
Medroxyprogesterone Acetate—Progesterone—CYP3A4—bone cancer	0.000161	0.0478	CrCbGaD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—JUN—bone cancer	0.000159	0.00209	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—ENO2—bone cancer	0.000158	0.00207	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TGFBR2—bone cancer	0.000157	0.00207	CbGpPWpGaD
Medroxyprogesterone Acetate—Hepatitis—Methotrexate—bone cancer	0.000157	0.000898	CcSEcCtD
Medroxyprogesterone Acetate—Sweating—Epirubicin—bone cancer	0.000157	0.000897	CcSEcCtD
Medroxyprogesterone Acetate—Pollakiuria—Doxorubicin—bone cancer	0.000157	0.000897	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000157	0.00207	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—bone cancer	0.000156	0.00206	CbGpPWpGaD
Medroxyprogesterone Acetate—Pharyngitis—Methotrexate—bone cancer	0.000156	0.000891	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—ATF-2 transcription factor network—JUN—bone cancer	0.000156	0.00205	CbGpPWpGaD
Medroxyprogesterone Acetate—Urinary tract disorder—Methotrexate—bone cancer	0.000155	0.000886	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Epirubicin—bone cancer	0.000155	0.000885	CcSEcCtD
Medroxyprogesterone Acetate—Weight increased—Doxorubicin—bone cancer	0.000155	0.000884	CcSEcCtD
Medroxyprogesterone Acetate—Epistaxis—Epirubicin—bone cancer	0.000155	0.000882	CcSEcCtD
Medroxyprogesterone Acetate—AR—Regulation of nuclear beta catenin signaling and target gene transcription—MMP9—bone cancer	0.000154	0.00203	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000154	0.00203	CbGpPWpGaD
Medroxyprogesterone Acetate—Urethral disorder—Methotrexate—bone cancer	0.000154	0.00088	CcSEcCtD
Medroxyprogesterone Acetate—Weight decreased—Doxorubicin—bone cancer	0.000154	0.000878	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Epirubicin—bone cancer	0.000154	0.000878	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—BRCA2—bone cancer	0.000154	0.00202	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperglycaemia—Doxorubicin—bone cancer	0.000154	0.000876	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—FUS—bone cancer	0.000153	0.00202	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—IL3—bone cancer	0.000153	0.00201	CbGpPWpGaD
Medroxyprogesterone Acetate—Testosterone—CYP3A4—bone cancer	0.000152	0.0452	CrCbGaD
Medroxyprogesterone Acetate—Infestation NOS—Doxorubicin—bone cancer	0.000152	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Infestation—Doxorubicin—bone cancer	0.000152	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Drowsiness—Doxorubicin—bone cancer	0.000152	0.000866	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Methotrexate—bone cancer	0.000152	0.000865	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—bone cancer	0.00015	0.00198	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Cisplatin—bone cancer	0.00015	0.000856	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Epirubicin—bone cancer	0.00015	0.000855	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Aryl Hydrocarbon Receptor—EGFR—bone cancer	0.00015	0.00197	CbGpPWpGaD
Medroxyprogesterone Acetate—Erythema multiforme—Methotrexate—bone cancer	0.000149	0.000849	CcSEcCtD
Medroxyprogesterone Acetate—Neuropathy peripheral—Doxorubicin—bone cancer	0.000149	0.000849	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000148	0.00195	CbGpPWpGaD
Medroxyprogesterone Acetate—Haemoglobin—Epirubicin—bone cancer	0.000148	0.000844	CcSEcCtD
Medroxyprogesterone Acetate—Jaundice—Doxorubicin—bone cancer	0.000148	0.000844	CcSEcCtD
Medroxyprogesterone Acetate—Stomatitis—Doxorubicin—bone cancer	0.000148	0.000844	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract infection—Doxorubicin—bone cancer	0.000148	0.000841	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Epirubicin—bone cancer	0.000147	0.00084	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Epirubicin—bone cancer	0.000147	0.00084	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Methotrexate—bone cancer	0.000147	0.000839	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Methotrexate—bone cancer	0.000147	0.000837	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—DHFR—bone cancer	0.000146	0.00192	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Cisplatin—bone cancer	0.000146	0.000834	CcSEcCtD
Medroxyprogesterone Acetate—Pharyngitis—Epirubicin—bone cancer	0.000146	0.000834	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Validated nuclear estrogen receptor alpha network—JUN—bone cancer	0.000146	0.00192	CbGpPWpGaD
Medroxyprogesterone Acetate—Cardiac disorder—Methotrexate—bone cancer	0.000146	0.000833	CcSEcCtD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—JUN—bone cancer	0.000146	0.00192	CbGpPWpGaD
Medroxyprogesterone Acetate—Sweating—Doxorubicin—bone cancer	0.000146	0.00083	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Epirubicin—bone cancer	0.000145	0.000829	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Epirubicin—bone cancer	0.000145	0.000827	CcSEcCtD
Medroxyprogesterone Acetate—Connective tissue disorder—Epirubicin—bone cancer	0.000145	0.000825	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Epirubicin—bone cancer	0.000144	0.000823	CcSEcCtD
Medroxyprogesterone Acetate—Hepatobiliary disease—Doxorubicin—bone cancer	0.000144	0.000819	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—MDM2—bone cancer	0.000143	0.00189	CbGpPWpGaD
Medroxyprogesterone Acetate—Epistaxis—Doxorubicin—bone cancer	0.000143	0.000817	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Methotrexate—bone cancer	0.000143	0.000814	CcSEcCtD
Medroxyprogesterone Acetate—Sinusitis—Doxorubicin—bone cancer	0.000142	0.000812	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Methotrexate—bone cancer	0.000142	0.000811	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Epirubicin—bone cancer	0.000142	0.000809	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Methotrexate—bone cancer	0.000142	0.000809	CcSEcCtD
Medroxyprogesterone Acetate—Chills—Methotrexate—bone cancer	0.000141	0.000805	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Cisplatin—bone cancer	0.000139	0.000795	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Epirubicin—bone cancer	0.000139	0.000794	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—JUN—bone cancer	0.000139	0.00183	CbGpPWpGaD
Medroxyprogesterone Acetate—Alopecia—Methotrexate—bone cancer	0.000139	0.000793	CcSEcCtD
Medroxyprogesterone Acetate—Bradycardia—Doxorubicin—bone cancer	0.000139	0.000791	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Methotrexate—bone cancer	0.000138	0.000786	CcSEcCtD
Medroxyprogesterone Acetate—Eye disorder—Epirubicin—bone cancer	0.000138	0.000785	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Epirubicin—bone cancer	0.000137	0.000783	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Methotrexate—bone cancer	0.000137	0.000781	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Methotrexate—bone cancer	0.000137	0.000781	CcSEcCtD
Medroxyprogesterone Acetate—Haemoglobin—Doxorubicin—bone cancer	0.000137	0.000781	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GNA11—bone cancer	0.000137	0.0018	CbGpPWpGaD
Medroxyprogesterone Acetate—Cardiac disorder—Epirubicin—bone cancer	0.000137	0.00078	CcSEcCtD
Medroxyprogesterone Acetate—Hepatitis—Doxorubicin—bone cancer	0.000136	0.000777	CcSEcCtD
Medroxyprogesterone Acetate—Haemorrhage—Doxorubicin—bone cancer	0.000136	0.000777	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—JUN—bone cancer	0.000136	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—MDM2—bone cancer	0.000136	0.00179	CbGpPWpGaD
Medroxyprogesterone Acetate—Pharyngitis—Doxorubicin—bone cancer	0.000135	0.000771	CcSEcCtD
Medroxyprogesterone Acetate—Urinary tract disorder—Doxorubicin—bone cancer	0.000135	0.000767	CcSEcCtD
Medroxyprogesterone Acetate—Oedema peripheral—Doxorubicin—bone cancer	0.000134	0.000766	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Methotrexate—bone cancer	0.000134	0.000765	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—JUN—bone cancer	0.000134	0.00176	CbGpPWpGaD
Medroxyprogesterone Acetate—Connective tissue disorder—Doxorubicin—bone cancer	0.000134	0.000764	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Epirubicin—bone cancer	0.000134	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Urethral disorder—Doxorubicin—bone cancer	0.000134	0.000762	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Epirubicin—bone cancer	0.000133	0.000759	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Epirubicin—bone cancer	0.000133	0.000757	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—LKB1 signaling events—TP53—bone cancer	0.000133	0.00174	CbGpPWpGaD
Medroxyprogesterone Acetate—Back pain—Methotrexate—bone cancer	0.000132	0.000756	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—MMP9—bone cancer	0.000132	0.00174	CbGpPWpGaD
Medroxyprogesterone Acetate—Chills—Epirubicin—bone cancer	0.000132	0.000754	CcSEcCtD
Medroxyprogesterone Acetate—Visual impairment—Doxorubicin—bone cancer	0.000131	0.000749	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000131	0.00172	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—MMP9—bone cancer	0.00013	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—Alopecia—Epirubicin—bone cancer	0.00013	0.000742	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Generic Transcription Pathway—NR1I2—bone cancer	0.00013	0.00171	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Cisplatin—bone cancer	0.00013	0.000739	CcSEcCtD
Medroxyprogesterone Acetate—Mental disorder—Epirubicin—bone cancer	0.000129	0.000736	CcSEcCtD
Medroxyprogesterone Acetate—Erythema multiforme—Doxorubicin—bone cancer	0.000129	0.000735	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—RB1—bone cancer	0.000129	0.00169	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Cisplatin—bone cancer	0.000128	0.000733	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Cisplatin—bone cancer	0.000128	0.000732	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Epirubicin—bone cancer	0.000128	0.000731	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Epirubicin—bone cancer	0.000128	0.000731	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Generic Transcription Pathway—NR1I2—bone cancer	0.000128	0.00168	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.000128	0.00168	CbGpPWpGaD
Medroxyprogesterone Acetate—Eye disorder—Doxorubicin—bone cancer	0.000127	0.000726	CcSEcCtD
Medroxyprogesterone Acetate—Ill-defined disorder—Methotrexate—bone cancer	0.000127	0.000725	CcSEcCtD
Medroxyprogesterone Acetate—Tinnitus—Doxorubicin—bone cancer	0.000127	0.000725	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Methotrexate—bone cancer	0.000127	0.000722	CcSEcCtD
Medroxyprogesterone Acetate—Cardiac disorder—Doxorubicin—bone cancer	0.000126	0.000721	CcSEcCtD
Medroxyprogesterone Acetate—Flatulence—Epirubicin—bone cancer	0.000126	0.00072	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Epirubicin—bone cancer	0.000126	0.000717	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Epirubicin—bone cancer	0.000126	0.000716	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Epirubicin—bone cancer	0.000125	0.00071	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—CYP3A4—bone cancer	0.000124	0.00163	CbGpPWpGaD
Medroxyprogesterone Acetate—Back pain—Epirubicin—bone cancer	0.000124	0.000707	CcSEcCtD
Medroxyprogesterone Acetate—Angiopathy—Doxorubicin—bone cancer	0.000124	0.000705	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Methotrexate—bone cancer	0.000124	0.000705	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	0.000123	0.00162	CbGpPWpGaD
Medroxyprogesterone Acetate—Muscle spasms—Epirubicin—bone cancer	0.000123	0.000703	CcSEcCtD
Medroxyprogesterone Acetate—Immune system disorder—Doxorubicin—bone cancer	0.000123	0.000702	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Methotrexate—bone cancer	0.000123	0.000702	CcSEcCtD
Medroxyprogesterone Acetate—Mediastinal disorder—Doxorubicin—bone cancer	0.000123	0.0007	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.000123	0.00161	CbGpPWpGaD
Medroxyprogesterone Acetate—Chills—Doxorubicin—bone cancer	0.000122	0.000697	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000121	0.00159	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Cisplatin—bone cancer	0.000121	0.00069	CcSEcCtD
Medroxyprogesterone Acetate—Alopecia—Doxorubicin—bone cancer	0.00012	0.000687	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Arachidonic acid metabolism—PTGS2—bone cancer	0.00012	0.00158	CbGpPWpGaD
Medroxyprogesterone Acetate—Mental disorder—Doxorubicin—bone cancer	0.000119	0.000681	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—bone cancer	0.000119	0.00157	CbGpPWpGaD
Medroxyprogesterone Acetate—Ill-defined disorder—Epirubicin—bone cancer	0.000119	0.000678	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Methotrexate—bone cancer	0.000119	0.000677	CcSEcCtD
Medroxyprogesterone Acetate—Erythema—Doxorubicin—bone cancer	0.000119	0.000677	CcSEcCtD
Medroxyprogesterone Acetate—Malnutrition—Doxorubicin—bone cancer	0.000119	0.000677	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Epirubicin—bone cancer	0.000118	0.000676	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—JUN—bone cancer	0.000118	0.00155	CbGpPWpGaD
Medroxyprogesterone Acetate—Agitation—Epirubicin—bone cancer	0.000118	0.000672	CcSEcCtD
Medroxyprogesterone Acetate—AR—Gene Expression—FUS—bone cancer	0.000117	0.00154	CbGpPWpGaD
Medroxyprogesterone Acetate—Flatulence—Doxorubicin—bone cancer	0.000117	0.000667	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Methotrexate—bone cancer	0.000117	0.000665	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Methotrexate—bone cancer	0.000117	0.000665	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Methotrexate—bone cancer	0.000117	0.000665	CcSEcCtD
Medroxyprogesterone Acetate—Tension—Doxorubicin—bone cancer	0.000116	0.000664	CcSEcCtD
Medroxyprogesterone Acetate—Dysgeusia—Doxorubicin—bone cancer	0.000116	0.000662	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000116	0.000661	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Epirubicin—bone cancer	0.000116	0.000659	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Methotrexate—bone cancer	0.000115	0.000657	CcSEcCtD
Medroxyprogesterone Acetate—Nervousness—Doxorubicin—bone cancer	0.000115	0.000657	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Epirubicin—bone cancer	0.000115	0.000657	CcSEcCtD
Medroxyprogesterone Acetate—Syncope—Epirubicin—bone cancer	0.000115	0.000656	CcSEcCtD
Medroxyprogesterone Acetate—Back pain—Doxorubicin—bone cancer	0.000115	0.000654	CcSEcCtD
Medroxyprogesterone Acetate—AR—Androgen receptor signaling pathway—EGFR—bone cancer	0.000115	0.00151	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—CDK4—bone cancer	0.000114	0.0015	CbGpPWpGaD
Medroxyprogesterone Acetate—Muscle spasms—Doxorubicin—bone cancer	0.000114	0.00065	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Epirubicin—bone cancer	0.000113	0.000646	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Methotrexate—bone cancer	0.000113	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Epirubicin—bone cancer	0.000113	0.000643	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Methotrexate—bone cancer	0.000112	0.000638	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Epirubicin—bone cancer	0.000111	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Methotrexate—bone cancer	0.000111	0.000633	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Adipogenesis—RB1—bone cancer	0.00011	0.00145	CbGpPWpGaD
Medroxyprogesterone Acetate—Ill-defined disorder—Doxorubicin—bone cancer	0.00011	0.000628	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—MDM2—bone cancer	0.00011	0.00144	CbGpPWpGaD
Medroxyprogesterone Acetate—Nervous system disorder—Methotrexate—bone cancer	0.00011	0.000625	CcSEcCtD
Medroxyprogesterone Acetate—Anaemia—Doxorubicin—bone cancer	0.00011	0.000625	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Regulation of Telomerase—EGFR—bone cancer	0.000109	0.00144	CbGpPWpGaD
Medroxyprogesterone Acetate—Thrombocytopenia—Methotrexate—bone cancer	0.000109	0.000624	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Epirubicin—bone cancer	0.000109	0.000622	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Epirubicin—bone cancer	0.000109	0.000622	CcSEcCtD
Medroxyprogesterone Acetate—Myalgia—Epirubicin—bone cancer	0.000109	0.000622	CcSEcCtD
Medroxyprogesterone Acetate—Agitation—Doxorubicin—bone cancer	0.000109	0.000622	CcSEcCtD
Medroxyprogesterone Acetate—Anxiety—Epirubicin—bone cancer	0.000109	0.00062	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Methotrexate—bone cancer	0.000109	0.000619	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.000108	0.000618	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Methotrexate—bone cancer	0.000108	0.000616	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Epirubicin—bone cancer	0.000108	0.000615	CcSEcCtD
Medroxyprogesterone Acetate—Malaise—Doxorubicin—bone cancer	0.000107	0.00061	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—KIT—bone cancer	0.000107	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—Dry mouth—Epirubicin—bone cancer	0.000107	0.000609	CcSEcCtD
Medroxyprogesterone Acetate—Vertigo—Doxorubicin—bone cancer	0.000107	0.000608	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Methotrexate—bone cancer	0.000107	0.000608	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—NR1I2—bone cancer	0.000106	0.0014	CbGpPWpGaD
Medroxyprogesterone Acetate—Syncope—Doxorubicin—bone cancer	0.000106	0.000607	CcSEcCtD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—GSTP1—bone cancer	0.000106	0.00139	CbGpPWpGaD
Medroxyprogesterone Acetate—Confusional state—Epirubicin—bone cancer	0.000105	0.000602	CcSEcCtD
Medroxyprogesterone Acetate—Palpitations—Doxorubicin—bone cancer	0.000105	0.000598	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Epirubicin—bone cancer	0.000105	0.000597	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Epirubicin—bone cancer	0.000105	0.000597	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Methotrexate—bone cancer	0.000104	0.000596	CcSEcCtD
Medroxyprogesterone Acetate—Loss of consciousness—Doxorubicin—bone cancer	0.000104	0.000595	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Epirubicin—bone cancer	0.000104	0.000593	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Epirubicin—bone cancer	0.000103	0.000587	CcSEcCtD
Medroxyprogesterone Acetate—Convulsion—Doxorubicin—bone cancer	0.000103	0.000586	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Epirubicin—bone cancer	0.000103	0.000585	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Epirubicin—bone cancer	0.000102	0.000584	CcSEcCtD
Medroxyprogesterone Acetate—Tachycardia—Epirubicin—bone cancer	0.000102	0.000582	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Methotrexate—bone cancer	0.000102	0.000581	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Epirubicin—bone cancer	0.000102	0.00058	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—RGS1—bone cancer	0.000101	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GRM4—bone cancer	0.000101	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—Hyperhidrosis—Epirubicin—bone cancer	0.000101	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Methotrexate—bone cancer	0.000101	0.000577	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—BRAF—bone cancer	0.000101	0.00133	CbGpPWpGaD
Medroxyprogesterone Acetate—Myalgia—Doxorubicin—bone cancer	0.000101	0.000576	CcSEcCtD
Medroxyprogesterone Acetate—Chest pain—Doxorubicin—bone cancer	0.000101	0.000576	CcSEcCtD
Medroxyprogesterone Acetate—Arthralgia—Doxorubicin—bone cancer	0.000101	0.000576	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—CYP3A4—bone cancer	0.000101	0.00132	CbGpPWpGaD
Medroxyprogesterone Acetate—Anxiety—Doxorubicin—bone cancer	0.000101	0.000574	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Methotrexate—bone cancer	0.0001	0.000573	CcSEcCtD
Medroxyprogesterone Acetate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.0001	0.000572	CcSEcCtD
Medroxyprogesterone Acetate—Discomfort—Doxorubicin—bone cancer	9.98e-05	0.000569	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Epirubicin—bone cancer	9.97e-05	0.000569	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Methotrexate—bone cancer	9.97e-05	0.000568	CcSEcCtD
Medroxyprogesterone Acetate—Somnolence—Methotrexate—bone cancer	9.94e-05	0.000567	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—CYP3A4—bone cancer	9.94e-05	0.00131	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—RB1—bone cancer	9.92e-05	0.0013	CbGpPWpGaD
Medroxyprogesterone Acetate—Dry mouth—Doxorubicin—bone cancer	9.88e-05	0.000563	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Methotrexate—bone cancer	9.84e-05	0.000561	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling by ERBB4—EGFR—bone cancer	9.8e-05	0.00129	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypotension—Epirubicin—bone cancer	9.78e-05	0.000558	CcSEcCtD
Medroxyprogesterone Acetate—Confusional state—Doxorubicin—bone cancer	9.76e-05	0.000557	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Arachidonic acid metabolism—PTGS2—bone cancer	9.76e-05	0.00128	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Methotrexate—bone cancer	9.72e-05	0.000554	CcSEcCtD
Medroxyprogesterone Acetate—Anaphylactic shock—Doxorubicin—bone cancer	9.68e-05	0.000552	CcSEcCtD
Medroxyprogesterone Acetate—Oedema—Doxorubicin—bone cancer	9.68e-05	0.000552	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Methotrexate—bone cancer	9.65e-05	0.00055	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Methotrexate—bone cancer	9.64e-05	0.00055	CcSEcCtD
Medroxyprogesterone Acetate—Infection—Doxorubicin—bone cancer	9.62e-05	0.000549	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—JUN—bone cancer	9.55e-05	0.00126	CbGpPWpGaD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Epirubicin—bone cancer	9.53e-05	0.000544	CcSEcCtD
Medroxyprogesterone Acetate—Shock—Doxorubicin—bone cancer	9.52e-05	0.000543	CcSEcCtD
Medroxyprogesterone Acetate—Nervous system disorder—Doxorubicin—bone cancer	9.49e-05	0.000541	CcSEcCtD
Medroxyprogesterone Acetate—Thrombocytopenia—Doxorubicin—bone cancer	9.48e-05	0.000541	CcSEcCtD
Medroxyprogesterone Acetate—Insomnia—Epirubicin—bone cancer	9.46e-05	0.00054	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	9.46e-05	0.00124	CbGpPWpGaD
Medroxyprogesterone Acetate—Tachycardia—Doxorubicin—bone cancer	9.45e-05	0.000539	CcSEcCtD
Medroxyprogesterone Acetate—Skin disorder—Doxorubicin—bone cancer	9.4e-05	0.000536	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Epirubicin—bone cancer	9.39e-05	0.000536	CcSEcCtD
Medroxyprogesterone Acetate—Hyperhidrosis—Doxorubicin—bone cancer	9.36e-05	0.000534	CcSEcCtD
Medroxyprogesterone Acetate—Dyspnoea—Epirubicin—bone cancer	9.33e-05	0.000532	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—ENO2—bone cancer	9.31e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—SIDS Susceptibility Pathways—JUN—bone cancer	9.3e-05	0.00122	CbGpPWpGaD
Medroxyprogesterone Acetate—Somnolence—Epirubicin—bone cancer	9.3e-05	0.00053	CcSEcCtD
Medroxyprogesterone Acetate—Anorexia—Doxorubicin—bone cancer	9.23e-05	0.000526	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Methotrexate—bone cancer	9.21e-05	0.000525	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Epirubicin—bone cancer	9.21e-05	0.000525	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Methotrexate—bone cancer	9.14e-05	0.000521	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	9.1e-05	0.0012	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Epirubicin—bone cancer	9.09e-05	0.000519	CcSEcCtD
Medroxyprogesterone Acetate—Hypotension—Doxorubicin—bone cancer	9.05e-05	0.000516	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Epirubicin—bone cancer	9.03e-05	0.000515	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Epirubicin—bone cancer	9.02e-05	0.000514	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Gene Expression—FUS—bone cancer	9.01e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—AP-1 transcription factor network—TP53—bone cancer	8.98e-05	0.00118	CbGpPWpGaD
Medroxyprogesterone Acetate—Constipation—Epirubicin—bone cancer	8.95e-05	0.00051	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Methotrexate—bone cancer	8.88e-05	0.000507	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—FUS—bone cancer	8.87e-05	0.00117	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—AP-1 transcription factor network—TP53—bone cancer	8.84e-05	0.00116	CbGpPWpGaD
Medroxyprogesterone Acetate—Body temperature increased—Methotrexate—bone cancer	8.84e-05	0.000504	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Methotrexate—bone cancer	8.84e-05	0.000504	CcSEcCtD
Medroxyprogesterone Acetate—Musculoskeletal discomfort—Doxorubicin—bone cancer	8.82e-05	0.000503	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	8.77e-05	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GRM1—bone cancer	8.77e-05	0.00115	CbGpPWpGaD
Medroxyprogesterone Acetate—Insomnia—Doxorubicin—bone cancer	8.76e-05	0.000499	CcSEcCtD
Medroxyprogesterone Acetate—Paraesthesia—Doxorubicin—bone cancer	8.69e-05	0.000496	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Disease—DHFR—bone cancer	8.63e-05	0.00114	CbGpPWpGaD
Medroxyprogesterone Acetate—Dyspnoea—Doxorubicin—bone cancer	8.63e-05	0.000492	CcSEcCtD
Medroxyprogesterone Acetate—Feeling abnormal—Epirubicin—bone cancer	8.62e-05	0.000492	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Biological oxidations—GSTP1—bone cancer	8.62e-05	0.00113	CbGpPWpGaD
Medroxyprogesterone Acetate—Somnolence—Doxorubicin—bone cancer	8.61e-05	0.000491	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Epirubicin—bone cancer	8.56e-05	0.000488	CcSEcCtD
Medroxyprogesterone Acetate—Dyspepsia—Doxorubicin—bone cancer	8.52e-05	0.000486	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metapathway biotransformation—GSTP1—bone cancer	8.5e-05	0.00112	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—MDM2—bone cancer	8.46e-05	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—MDM2—bone cancer	8.42e-05	0.00111	CbGpPWpGaD
Medroxyprogesterone Acetate—Decreased appetite—Doxorubicin—bone cancer	8.42e-05	0.00048	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal disorder—Doxorubicin—bone cancer	8.36e-05	0.000477	CcSEcCtD
Medroxyprogesterone Acetate—Fatigue—Doxorubicin—bone cancer	8.35e-05	0.000476	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Epirubicin—bone cancer	8.31e-05	0.000474	CcSEcCtD
Medroxyprogesterone Acetate—Constipation—Doxorubicin—bone cancer	8.28e-05	0.000472	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Epirubicin—bone cancer	8.27e-05	0.000472	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Epirubicin—bone cancer	8.27e-05	0.000472	CcSEcCtD
Medroxyprogesterone Acetate—Hypersensitivity—Methotrexate—bone cancer	8.24e-05	0.00047	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—CYP3A4—bone cancer	8.2e-05	0.00108	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—NR1I2—bone cancer	8.11e-05	0.00107	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—CYP3A4—bone cancer	8.09e-05	0.00106	CbGpPWpGaD
Medroxyprogesterone Acetate—Asthenia—Methotrexate—bone cancer	8.02e-05	0.000457	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GRM4—bone cancer	7.98e-05	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—RGS1—bone cancer	7.98e-05	0.00105	CbGpPWpGaD
Medroxyprogesterone Acetate—Feeling abnormal—Doxorubicin—bone cancer	7.98e-05	0.000455	CcSEcCtD
Medroxyprogesterone Acetate—Gastrointestinal pain—Doxorubicin—bone cancer	7.92e-05	0.000451	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	7.91e-05	0.00104	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Methotrexate—bone cancer	7.91e-05	0.000451	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—EIF2S1—bone cancer	7.86e-05	0.00103	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—ENO2—bone cancer	7.79e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Glucocorticoid receptor regulatory network—TP53—bone cancer	7.79e-05	0.00102	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Epirubicin—bone cancer	7.71e-05	0.00044	CcSEcCtD
Medroxyprogesterone Acetate—Urticaria—Doxorubicin—bone cancer	7.69e-05	0.000439	CcSEcCtD
Medroxyprogesterone Acetate—Body temperature increased—Doxorubicin—bone cancer	7.65e-05	0.000436	CcSEcCtD
Medroxyprogesterone Acetate—Abdominal pain—Doxorubicin—bone cancer	7.65e-05	0.000436	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Methotrexate—bone cancer	7.65e-05	0.000436	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Epirubicin—bone cancer	7.51e-05	0.000428	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—EGFR—bone cancer	7.51e-05	0.000987	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Epirubicin—bone cancer	7.4e-05	0.000422	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Methotrexate—bone cancer	7.39e-05	0.000422	CcSEcCtD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—JUN—bone cancer	7.35e-05	0.000967	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—DHFR—bone cancer	7.23e-05	0.000951	CbGpPWpGaD
Medroxyprogesterone Acetate—Diarrhoea—Epirubicin—bone cancer	7.16e-05	0.000408	CcSEcCtD
Medroxyprogesterone Acetate—CYP3A4—Tryptophan metabolism—MDM2—bone cancer	7.14e-05	0.000938	CbGpPWpGaD
Medroxyprogesterone Acetate—Hypersensitivity—Doxorubicin—bone cancer	7.13e-05	0.000407	CcSEcCtD
Medroxyprogesterone Acetate—Vomiting—Methotrexate—bone cancer	7.11e-05	0.000405	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—SIDS Susceptibility Pathways—JUN—bone cancer	7.06e-05	0.000928	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Methotrexate—bone cancer	7.05e-05	0.000402	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Methotrexate—bone cancer	7.04e-05	0.000402	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C9—Biological oxidations—GSTP1—bone cancer	7.01e-05	0.000922	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	7.01e-05	0.000922	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Methotrexate—bone cancer	7e-05	0.000399	CcSEcCtD
Medroxyprogesterone Acetate—Asthenia—Doxorubicin—bone cancer	6.95e-05	0.000396	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Epirubicin—bone cancer	6.92e-05	0.000395	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GRM1—bone cancer	6.92e-05	0.000909	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metapathway biotransformation—GSTP1—bone cancer	6.92e-05	0.000909	CbGpPWpGaD
Medroxyprogesterone Acetate—Pruritus—Doxorubicin—bone cancer	6.85e-05	0.000391	CcSEcCtD
Medroxyprogesterone Acetate—PGR—Gene Expression—EZH2—bone cancer	6.83e-05	0.000897	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	6.76e-05	0.000889	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GNA11—bone cancer	6.76e-05	0.000889	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Epirubicin—bone cancer	6.65e-05	0.000379	CcSEcCtD
Medroxyprogesterone Acetate—Nausea—Methotrexate—bone cancer	6.64e-05	0.000379	CcSEcCtD
Medroxyprogesterone Acetate—Diarrhoea—Doxorubicin—bone cancer	6.62e-05	0.000378	CcSEcCtD
Medroxyprogesterone Acetate—Rash—Epirubicin—bone cancer	6.6e-05	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Epirubicin—bone cancer	6.59e-05	0.000376	CcSEcCtD
Medroxyprogesterone Acetate—Headache—Epirubicin—bone cancer	6.55e-05	0.000374	CcSEcCtD
Medroxyprogesterone Acetate—Dizziness—Doxorubicin—bone cancer	6.4e-05	0.000365	CcSEcCtD
Medroxyprogesterone Acetate—AR—Integrated Breast Cancer Pathway—TP53—bone cancer	6.3e-05	0.000828	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—TGFBR2—bone cancer	6.26e-05	0.000823	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—NR1I2—bone cancer	6.24e-05	0.000821	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	6.22e-05	0.000818	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Epirubicin—bone cancer	6.21e-05	0.000354	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—SMO—bone cancer	6.18e-05	0.000812	CbGpPWpGaD
Medroxyprogesterone Acetate—Vomiting—Doxorubicin—bone cancer	6.15e-05	0.000351	CcSEcCtD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—NR1I2—bone cancer	6.15e-05	0.000809	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—CYP3A4—bone cancer	6.13e-05	0.000806	CbGpPWpGaD
Medroxyprogesterone Acetate—Rash—Doxorubicin—bone cancer	6.1e-05	0.000348	CcSEcCtD
Medroxyprogesterone Acetate—Dermatitis—Doxorubicin—bone cancer	6.1e-05	0.000348	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	6.1e-05	0.000801	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	6.09e-05	0.000801	CbGpPWpGaD
Medroxyprogesterone Acetate—Headache—Doxorubicin—bone cancer	6.06e-05	0.000346	CcSEcCtD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NDUFA12—bone cancer	6.04e-05	0.000794	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—EIF2S1—bone cancer	5.99e-05	0.000787	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—EGFR—bone cancer	5.78e-05	0.00076	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling by ERBB4—EGFR—bone cancer	5.75e-05	0.000756	CbGpPWpGaD
Medroxyprogesterone Acetate—Nausea—Doxorubicin—bone cancer	5.75e-05	0.000328	CcSEcCtD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—GNA11—bone cancer	5.65e-05	0.000743	CbGpPWpGaD
Medroxyprogesterone Acetate—HSD3B2—Metabolism—PTGS2—bone cancer	5.5e-05	0.000723	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—ATF1—bone cancer	5.25e-05	0.000691	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—GSTP1—bone cancer	5.24e-05	0.000689	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	5.22e-05	0.000687	CbGpPWpGaD
Medroxyprogesterone Acetate—AR—Gene Expression—EZH2—bone cancer	5.2e-05	0.000684	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IL3—bone cancer	5.12e-05	0.000674	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—NT5C3A—bone cancer	5e-05	0.000658	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NDUFA12—bone cancer	4.91e-05	0.000646	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—SMO—bone cancer	4.87e-05	0.000641	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Breast Cancer Pathway—TP53—bone cancer	4.85e-05	0.000638	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	4.79e-05	0.00063	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—RGS1—bone cancer	4.68e-05	0.000616	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GRM4—bone cancer	4.68e-05	0.000616	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Biological oxidations—GSTP1—bone cancer	4.62e-05	0.000608	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—EIF2S1—bone cancer	4.61e-05	0.000606	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	4.56e-05	0.0006	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—EIF2S1—bone cancer	4.54e-05	0.000597	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—GNA11—bone cancer	4.46e-05	0.000586	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TGFBR2—bone cancer	4.38e-05	0.000576	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—KIT—bone cancer	4.27e-05	0.000561	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—ATF1—bone cancer	4.14e-05	0.000545	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—IGF1R—bone cancer	4.12e-05	0.000542	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—NT5C3A—bone cancer	4.07e-05	0.000535	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GRM1—bone cancer	4.06e-05	0.000534	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IL3—bone cancer	4.04e-05	0.000531	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	4.02e-05	0.000529	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—BRAF—bone cancer	4.01e-05	0.000528	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Gene Expression—EZH2—bone cancer	4.01e-05	0.000527	CbGpPWpGaD
Medroxyprogesterone Acetate—NR3C1—Gene Expression—EZH2—bone cancer	3.95e-05	0.000519	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TGFBR2—bone cancer	3.46e-05	0.000454	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—MDM2—bone cancer	3.36e-05	0.000442	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—IGF1R—bone cancer	3.25e-05	0.000428	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—PTGS2—bone cancer	3.24e-05	0.000426	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NDUFA12—bone cancer	3.24e-05	0.000426	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—KIT—bone cancer	2.99e-05	0.000393	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—SMO—bone cancer	2.86e-05	0.000376	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—BRAF—bone cancer	2.81e-05	0.000369	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Metabolism—PTGS2—bone cancer	2.71e-05	0.000357	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—NT5C3A—bone cancer	2.69e-05	0.000353	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—GNA11—bone cancer	2.62e-05	0.000344	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—ATF1—bone cancer	2.43e-05	0.00032	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IL3—bone cancer	2.37e-05	0.000312	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—KIT—bone cancer	2.36e-05	0.00031	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MDM2—bone cancer	2.35e-05	0.00031	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Disease—EGFR—bone cancer	2.3e-05	0.000302	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—BRAF—bone cancer	2.22e-05	0.000291	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—ENO2—bone cancer	2.19e-05	0.000288	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—JUN—bone cancer	2.05e-05	0.000269	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—DHFR—bone cancer	2.03e-05	0.000267	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TGFBR2—bone cancer	2.03e-05	0.000267	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—MMP9—bone cancer	1.99e-05	0.000262	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—IGF1R—bone cancer	1.91e-05	0.000251	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GNA11—bone cancer	1.9e-05	0.00025	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MDM2—bone cancer	1.86e-05	0.000244	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—ENO2—bone cancer	1.78e-05	0.000234	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—CYP3A4—bone cancer	1.72e-05	0.000226	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.71e-05	0.000225	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—DHFR—bone cancer	1.65e-05	0.000218	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—JUN—bone cancer	1.61e-05	0.000212	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—EGFR—bone cancer	1.61e-05	0.000212	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—MMP9—bone cancer	1.57e-05	0.000207	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GNA11—bone cancer	1.55e-05	0.000203	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—GSTP1—bone cancer	1.47e-05	0.000194	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—CYP3A4—bone cancer	1.4e-05	0.000184	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.39e-05	0.000183	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—KIT—bone cancer	1.38e-05	0.000182	CbGpPWpGaD
Medroxyprogesterone Acetate—AKR1C3—Signaling Pathways—TP53—bone cancer	1.35e-05	0.000178	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—BRAF—bone cancer	1.3e-05	0.000171	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—EGFR—bone cancer	1.27e-05	0.000167	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—GSTP1—bone cancer	1.2e-05	0.000158	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—ENO2—bone cancer	1.18e-05	0.000155	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—DHFR—bone cancer	1.09e-05	0.000143	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MDM2—bone cancer	1.09e-05	0.000143	CbGpPWpGaD
Medroxyprogesterone Acetate—PGR—Signaling Pathways—TP53—bone cancer	1.07e-05	0.00014	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GNA11—bone cancer	1.02e-05	0.000134	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—JUN—bone cancer	9.48e-06	0.000125	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—MMP9—bone cancer	9.22e-06	0.000121	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—GSTP1—bone cancer	7.91e-06	0.000104	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C8—Metabolism—PTGS2—bone cancer	7.63e-06	0.0001	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—EGFR—bone cancer	7.45e-06	9.79e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—ESR1—Signaling Pathways—TP53—bone cancer	6.26e-06	8.22e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP2C9—Metabolism—PTGS2—bone cancer	6.21e-06	8.17e-05	CbGpPWpGaD
Medroxyprogesterone Acetate—CYP3A4—Metabolism—PTGS2—bone cancer	4.1e-06	5.39e-05	CbGpPWpGaD
